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Abstract The immune response to CSFV and the strat-
egies of this virus to evade and suppress the pigs’ immune
system are still poorly understood. Therefore, we investi-
gated the transcriptional response in the tonsils, median
retropharyngeal lymph node (MRLN), and spleen of pigs
infected with CSFV strains of similar origin with high,
moderate, and low virulence. Using a porcine spleen/
intestinal cDNA microarray, expression levels in RNA
pools prepared from infected tissue at 3 dpi (three pigs per
virus strain) were compared to levels in pools prepared
from uninfected homologue tissues (nine pigs). A total of
44 genes were found to be differentially expressed. The
genes were functionally clustered in six groups: innate and
adaptive immune response, interferon-regulated genes,
apoptosis, ubiquitin-mediated proteolysis, oxidative phos-
phorylation and cytoskeleton. Signiﬁcant up-regulation of
three IFN-c-induced genes in the MRLNs of pigs infected
with the low virulence strain was the only clear qualitative
difference in gene expression observed between the strains
with high, moderate and low virulence. Real-time PCR
analysis of four response genes in all individual samples
largely conﬁrmed the microarray data at 3 dpi. Additional
PCR analysis of infected tonsil, MRLN, and spleen sam-
ples collected at 7 and 10 dpi indicated that the strong
induction of expression of the antiviral response genes
chemokine CXCL10 and 20–50 oligoadenylate synthetase 2,
and of the TNF-related apoptosis-inducing ligand (TRAIL)
gene at 3 dpi, decreased to lower levels at 7 and 10 dpi. For
the highly and moderately virulent strains, this decrease in
antiviral and apoptotic gene expression coincided with
higher levels of virus in these immune tissues.
Introduction
Classical swine fever virus (CSFV), a member of the genus
Pestivirus, family Flaviviridae, causes a severe disease of
pigs that is characterized by fever, leucopenia and hem-
orrhage [65, 66]. Apoptosis has been demonstrated to be
the cause of lymphocyte death [58, 66], but the precise
mechanism by which CSFV causes apoptosis is still
unknown.
Innate immunity is a critical arm of pre-existing host
defence that functions to eliminate foreign pathogens
immediately after infection and subsequently directs the
adaptive immune response. Interferons (IFNs) are key
components of innate immunity. Through different signal-
transduction pathways, IFNs can promote the expression of
dozens of genes responsible for executing IFN-induced
anti-viral and anti-proliferative effects (reviewed in Ref.
[30]).
The best-characterized IFN-inducible components of the
antiviral response are the dsRNA-dependent protein kinase
R (PKR, alias eukaryotic translation initiation factor
2-alpha kinase 2), the 20–50 oligoadenylate synthetases
(OASs), the Mx proteins and the nitric oxide system (NO).
IFNs can control apoptosis by inducing a pro-apoptotic
state in uninfected cells For example, IFN has been shown
to inﬂuence the sensitivity of cells for apoptosis by
S. V. M. Durand   L. Mastebroek   W. L. A. Loeffen (&)
Central Veterinary Institute of Wageningen University
and Research Centre, P.O. Box 65, 8200 AB Lelystad,
The Netherlands
e-mail: willie.loeffen@wur.nl
S. V. M. Durand
e-mail: sdurand30f@gmail.com
M. M. Hulst   A. A. C. de Wit
Animal Sciences Group of Wageningen University and Research
Centre, P.O. Box 65, 8200 AB Lelystad, The Netherlands
123
Arch Virol (2009) 154:1417–1431
DOI 10.1007/s00705-009-0460-3inducing expression of both the ligand and the receptor of
FAS and TRAIL [71, 73]. In addition, IFNs can control the
T helper immune system by inducing a broad spectrum of
chemokines and cytokines such as CXCL10, which induce
the Th1 immune response [18].
Viruses employ numerous evasive strategies to impair
antiviral responses. In the case of CSFV, only a few viral
strategies have been identiﬁed. The CSFV Npro protein has
been described as a suppressor of IRF3 function in the IFN
expression pathway in infected cells [3, 7, 17, 42, 55, 56,
60] and has been shown to interact with IkBa, the NF-KB
inhibitor [23]. In addition, in CSFV-infected macrophages,
NO production is suppressed by up-regulation of arginase
activity [75]. However, those viral mechanisms only par-
tially explain the immune suppression caused by CSFV.
Therefore, CSFV most likely uses several other strategies
to impair different immune pathways, e.g., the function of
antigen-presenting cells, the regulation of apoptosis, anti-
viral responses and the complement system. These mech-
anisms have not yet been investigated for CSFV, and most
of the current knowledge has been gained from in vitro
experiments.
In this present study, we used micro-array and PCR
analysis to investigate the transcriptional response to rep-
lication of CSFV in relevant immune organs of pigs. Pigs
were infected with three different laboratory-derived vari-
ants of CSF virus strain Brescia [36], which were charac-
terized as highly virulent, moderately virulent, and avirulent
in earlier animal experiments [69]. However, because the
avirulent strain did cause some fever and leucopenia, we
will refer to it in this paper as low virulent. We identiﬁed
viral modulations of IFN-inducible antiviral, apoptotic and
chemotactic genes. To our knowledge, these data represent
the ﬁrst in vivo gene expression study that describes anti-
viral responses to CSFV.
Materials and methods
Study design
An animal experiment was carried out with four groups of
nine pigs each. Three groups were inoculated with the
highly, moderately or low virulent CSF strain, while the
fourth group was left untreated. In each group, three piglets
were euthanized at 3, 7 and 10 days post-inoculation (dpi)
for the collection of tissue samples.
Animals
Thirty-six 6-week-old piglets were obtained from a con-
ventional herd that was free of pestiviruses. Groups of four
piglets of the same sex and originating from the same litter
were selected from the herd. From each group of four, one
piglet was randomly assigned to one of the four treatment
groups.
Inoculation
On day 0, the piglets of groups 1–3 were inoculated
intranasally with 2 ml virus suspension (1 ml per nostril)
containing 10
5 TCID50 per ml of infectious virus, as
determined using SK6 cells. The viruses used were,
respectively, CoBrB (highly virulent: HV), C1.1.1 (low
virulent: LV) and C1.1.1/CoBrB (moderately virulent:
MV). Virus C1.1.1 is a cell-adapted variant of a Brescia
strain with low virulence, whereas CoBrB (CoBrB 476S) is
the virulent variant. Sequence analysis showed 29 nucleic
acid mutations in C1.1.1, resulting in nine amino acid
substitutions, compared to the sequence of CoBrB [36].
C1.1.1/CoBrB is a chimera from C1.1.1 and CoBrB,
essentially containing the structural proteins from C1.1.1
and the non-structural proteins from CoBrB [69]. The
control group was inoculated with 2 ml PBS instead.
Observation and scoring
From 3 days before the inoculation until they were eutha-
nized, the animals were observed on a daily basis for
clinical symptoms, and their rectal temperature was mea-
sured. A list of CSF-related clinical symptoms (lack of
appetite, diarrhoea, lethargy, inability to stand up, trem-
bling) was used and scored as either present or not present.
The scores for each pig were added up to a total score per
day.
Leucocyte count
EDTA blood samples were taken on days 0, 1, 2, 3, 4, 7,
and 10 from all pigs that were still alive. White blood cell
(leucocytes) and thrombocyte counts were performed using
a Medonic
 CA 620 coulter counter (Boule Medical AB,
Stockholm, Sweden). Leucopenia was deﬁned as \8 9
10
9 cells/l blood, and thrombocytopenia as \200 9 10
9
cells/l blood [12].
Post-mortem sampling
In each group, the ﬁrst three piglets were euthanized on the
ﬁrst day on which the rectal body temperature was[40C.
At 7 and 10 dpi, another three piglets were euthanized in
each group. Post-mortem tissue samples were collected
from the tonsils, spleen and median retropharyngeal lymph
node (MRLN). They were snap-frozen in liquid nitrogen
and stored at -80C until total RNA was isolated from
these samples.
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From 0.5 g of tissue, total RNA (DNase-free) was isolated
using TRIzol
 reagent (Invitrogen) as described recently
[50]. The yield and purity of the RNA was calculated from
measurements of the extinction at 260 and 280 nm. The
integrity of all RNA samples was checked by analyzing
0.5 lg of RNA on a 1% (w/v) agarose gel. After ethidium
bromide staining, the gel was scanned to calculate the 28S/
18S peak ratio (volume 28S over volume 18S) for each
RNA preparation. RNA with a ratio[2 was considered of
adequate quality to be used for real-time PCR and micro-
array analysis. For all RNA preparations, a 28S/18S ratio of
[2 was observed. A part of each RNA preparation was
used to prepare RNA pools for microarray analysis.
Microarray analysis
For microarray analysis a homemade porcine cDNA
microarray containing 2,928 probes from a jejunum EST
library [50] plus 2,880 probes from a spleen EST library
was used. For production of this spleen EST library,
spleens were collected from the same four 12-week-old
pigs from which the jejunal mucosal scrapings were
obtained for the preparation of the jejunum EST library
[50]. A total of 2,688 probes (ESTs) were generated from
total RNA isolated from pooled spleen tissue (n = 4 pigs).
In addition, 192 probes were generated from RNA isolated
from in vitro ConA/LPS-stimulated spleen cells derived
from the above-described pooled spleen tissue. Together
with the jejunum and spleen probes, an additional 192
cDNA probes selected from Marc1 and 2 EST libraries
[24], and probes coding for porcine cytokines (IFN-c,
TNF-a, GMCSF, IL-2, 4, 6, 8, and 10) and lung surfactant
proteins SFTPA and SFTPD were spotted in quadruplicate
on Corning UltraGAPS slides [31].
Dual-colour hybridization of slides was performed using
an RNA MICROMAX TSA labelling and detection kit
(Perkin-Elmer, Zoetermeer, The Netherlands) as described
earlier [50]. Brieﬂy, a biotin (BI)-labeled cDNA target was
prepared from 1 lg of RNA template from an uninfected
RNA pool, and a ﬂuorescein (FL)-labeled cDNA target was
prepared from 1 lg of RNA template from an infected
RNA pool. Labelled cDNAs were simultaneously hybrid-
ized to a microarray slide and detected with Cy5 (biotin)
and Cy3 (ﬂuorescein), respectively. For each comparison, a
second hybridization experiment was performed in which
the BI and FL labels were reversed (dye-swap). The slides
were scanned for Cy5 and Cy3 ﬂuorescence in a Packard
Bioscience BioChip Technologies apparatus (ScanArray
Express, Perkin-Elmer). Scan images were processed
with GenePix Pro 5.0 (Molecular Devices, Apeldoorn,
The Netherlands), automatically gridding the spots, and
measuring spot intensities. In addition, spots with irregular
shape were eliminated manually. An intensity-dependent
normalisation was performed (blank-speciﬁc background
correction; Lowess ﬁt function with a fraction of 0.2 on all
data points) using a customized version of the statistical
software package R [74]. Signiﬁcantly differentially
expressed spots with a ratio of [3.3 or \0.30 (M-value
of\-1.73 or[1.73; M = log2 (Cy5/Cy3)) and a p-value
\0.05 were selected manually from normalized data
reports. A probe was considered differentially expressed
when at least ﬁve out of the eight spots present on the two
dye-swaps passed these selection criteria. For each probe,
the mean ratio of differential expression (infected over
uninfected) of replicate spots (n C 5 and B8) is presented.
Probes that were yet not annotated were sequenced as
described previously [50].
Microarray comparisons
For each type of tissue, an RNA pool was prepared from
total RNA, isolated from three pigs originating from the
same infected group. At 3 dpi, these three piglets were
selected from the HV and MV groups on the basis of early
signs of fever (i.e., highest rectal temperature), and ran-
domly from the LV group (see above). In three separate
dye-swap hybridization experiments, mRNA expression
levels in infected spleen, tonsil, and lymph node pools were
compared to levels in RNA pools prepared from homo-
logue tissue collected from the nine uninfected (control)
pigs. Performing these tissue-speciﬁc microarrays for each
virus strain (HV, MV, LV) resulted in nine data sets of
probes hybridizing differentially with a fold change (ratio
infected over uninfected) of\0.30 or[3.3 (p-value\0.05).
Sequences of selected probes were annotated after blastn or
(t)blastx analysis (when not yet annotated).
Real-time PCR for CSFV
For the detection of CFSV, PCR assays were performed
using a LightCycler instrument with red dye, using the
RNA Master Hybprobes kit (Roche Applied Science,
Mannheim, Germany) [70]. Ct values were used to express
the amounts of virus in a semi-quantitative way.
Real-time PCR for gene expression
Gene-speciﬁc primers were developed from mRNA refer-
ence sequences (pig, cattle, human) found in sequence
databases (NBCI, KEGG). These reference sequences were
selected by homology search with EST sequences obtained
from the library probes. Primers were designed within the
open frame of the protein encoded by the gene of interest
and also, when possible, in different exons in order to
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sequences are listed in Table 1.
Randomly primed reverse transcription reactions were
carried out using the Transcriptor ﬁrst-strand cDNA syn-
thesis kit (Roche Applied Science, Mannheim, Germany)
with approximately 200 ng of RNA as template and 60 lM
hexamer primers. The produced cDNA was stored at
-20C until use. Real-time PCR tests were carried out with
a LightCycler instrument and a LightCycler FastStart DNA
Master SYBR Green I kit (Roche Applied Science,
Mannheim, Germany). The PCR conditions are listed in
Table 1. The relative concentration of mRNA was calcu-
lated by extrapolation on a standard curve prepared from
dilutions of an RT reaction prepared from a reference RNA
sample. The relative concentration of 18S and beta-actin
were determined once for each cDNA sample and used to
normalize concentrations of all other genes tested from the
same cDNA sample. Established quantities of 18S rRNA
and beta-actin showed essentially no differences among
any of the individual RNA samples (18S RNA average
relative concentration 1.15 ± 0.30; beta-actin average
relative concentration 0.54 ± 0.026).
Results
Clinical parameters after infection with CSFV strains
Pigs infected with the HV and MV virus strains developed
fever (above 40C) around 2–3 dpi together with a drop in
WBC count and, this was then followed by acute clinical
signs beginning 4 dpi (Fig. 1). Although the drop in
WBC’s and fever for LV-infected pigs coincided with
those of MV and HV-infected pigs, WBC concentrations
and rectal temperatures reached normal levels at 7 dpi.
Moreover, the moderate clinical signs observed in these
pigs dramatically declined from 8 until 10 dpi. These
results indicated that LV-infected pigs quickly recovered
from the infection. The pigs from the control group showed
normal clinical parameters during the whole animal
experiment (Fig. 1).
Gene expression analysis
Messenger RNA levels in CSFV-infected immune organs
at the port of entrance (tonsil and medial retropharyngeal
lymph node) and in the spleen at 3 dpi were compared to
levels in homologous tissues from uninfected pigs for all
three virus strains (LV, MV, and HV), using the home-
made cDNA microarray prepared from spleen and jeju-
num tissue. In these nine microarray comparisons, a total
of 44 different mRNAs (genes) hybridized differentially
with a ratio (fold change; infected over uninfected) of
\0.30 or [3.3 (p-value \0.05). Messenger RNA levels
were increased signiﬁcantly for 33 genes and reduced
signiﬁcantly for 11 genes. In Table 2,t h er a t i oo fd i f -
ferential expression calculated from the two dye-swap
slides is presented. Based on literature search and data
mining, a tentative function was assigned for the genes
identiﬁed by blast analysis. With the probes coding for
IFN-c,T N F - a, GM-CSF, IL-2, 4, 6, 8, and 10, the ﬂuo-
rescence intensity was never higher than the background
threshold.
Data mining and functional clustering
Based on their function, genes identiﬁed by microarray
analysis were clustered in six groups (Table 2): (1) genes
related to apoptosis (Apopt.), (2) IFN-a/b-o rc-induced
genes (IFN), (3) genes related to the adaptive and innate
immune response, including antigen presentation (innate/
adapt. Immune-AP), (4) genes related to the proteosome
pathway, i.e., ubiquitin-mediated proteolysis (UBM), (5)
components of, or proteins associated with the cytoskeleton
Table 1 Gene speciﬁc primer sequences and PCR conditions
Gene Acc. number Forward primer Reverse primer Tm
(C)
Reference
OAS2 AY288913 ACAGTCTTGAGGGGCAACTCTGA GCTGGCTTTCATCATATCCAAGGA 60
CXC10 AY789646 TGCCCACATGTTGAGATCAT CGGCCCATCCTTATCAGTAG 60
TRAIL NM_001024696 CAACAAGGCATTCCTCACCT CCAGCTCTCCATTCCTCAAG 60
IFN alpha NM_214393 TACTCAGCTGCAATGCCATC TCTGTGCTGAAGAGCTGGAA 58
18S RNA AF102857 GTTCAAAGCAGGCCCGAG CGCCGCCGCATCGCCA 57 De groot et al. (2005)
Beta actine AY550069.1 GGCATCCTGACCCTCAAGTA GGGTCATCTTCTCACGGTTG 58
C4-bp NM_213942 CTCTGGTTGGAGAGGACAGA GCTCACAGTCTTCGGGGTA 60
PCR conditions: 3 mM magnesium chloride and 0.5 mM for primer pair. The cycling PCR conditions consisted of 1 cycle at 95C for 50,
followed by 45 cycles (95C for 50, annealing temperature for 50,7 2 C for 120) and 1 three-segment cycle of product melting
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123(cytoskeleton), and (6) genes involved in oxidative phos-
phorylation, including oxygen transporters (Ox-P).
Up-regulated genes related to apoptosis included pro-
apoptotic genes such as TRAIL, which leads to caspase-
dependent cell death (reviewed in Ref. [64]) and the gene
for cathepsin C, a protease responsible for the proteolytic
maturation of granzyme [51], which induces apoptosis
through activation of caspase and the Bid protein [8, 11].
Anti-apoptotic genes were also induced, such as MCL1
(alias BCL2-related), which blocks apoptosis mediated by
ER-Ca
2? release and mitochondrial Cyt-c release [14], and
is also involved in the regulation of redox- and oxidant-
mediated apoptosis [32, 43]. In addition, genes related to
glutathione metabolism (GLRX, GCLM), which also pre-
vent redox- and oxidant-mediated apoptosis in the ER and
mitochondria, were up-regulated [32]. Calbindin, a cal-
cium-binding protein suppresses apoptosis by inhibiting
caspase 3 activity [5]. Although PARP genes are well
established as cell survival factors contributing to DNA
repair, recent work has indicated that they also induce cell
death via the p53 signalling pathway and via the intrinsic
pathway [16, 33].
IFN-regulated genes were all up-regulated. These
genes included IFN-c-induced genes AIF-1, IFI 16, GBP-
2, and MOP-5, and genes induced by IFN-a/b:I F I 4 4 ,
CXCL10, and OAS2. CXCL10 (alias IP10) is a pleio-
tropic cytokine that stimulates monocytes, natural killer
and T cell migration [18]. The antiviral enzyme OAS2
catalyses the synthesis of oligoadenylate chains in
response to dsRNA binding, which acts as an activator of
RNase L [61]. Active Rnase L degrades viral and cellular
RNAs, leading to inhibition of cellular protein synthesis
and impairment of viral replication (reviewed in Ref.
[62]). The proteins AIF1, IFI16, GBP2, MOP5, and IFI44
are involved in cell growth, cellular defence and cell
proliferation. Note that the up-regulation of the IFN-c-
induced genes AIF1, IFI16, and GBP2 in the MRLN of
LV-infected pigs at 3 dpi was not detected in pigs
infected with the MV and HV strains. Interestingly, it has
been reported that expression of AIF1 in vascular muscle
cells is induced in response to arterial injury, a phe-
nomenon also observed in CSFV pathogenesis [27], and
IFI16 inhibits vascular tube morphogenesis and prolifer-
ation of primary endothelial cells [52].
Up-regulated genes involved in the innate/adaptive
immune response include MHC1 genes such as SLA-1 and
B2M, the natural killer surface receptor CD16b and genes
such as immunoglobulins (J, lambda, kappa chains, heavy,
light chains, FC fragment), which are ubiquitously expres-
sed on the surface of B and T lymphocytes. The gene C4b
was down-regulated. C4bp is a regulatory component
(inhibitor) of the classical complement cascade [9] but also
acts as an activator of B cells (by binding to CD40) [15, 49]
and a protein that helps with the removal of apoptotic cells
by binding to protein S [10, 68].
Up-regulated genes involved in ubiquitin-mediated
proteolysis included a potential ubiquitine ligase (HERC6)
and components of the proteasome (UBC and Psma6).
Most of the genes found to be down-regulated were
structural components of the cytoskeleton (ACTA 2 and
TPM1), genes involved in oxygen binding and transport
(alpha–beta globin and ferroportin-1), or constituents of the
mitochondrial respiratory chain (oxidative phosphoryla-
tion) (CytB, ND6, ND4L and E-NPP 3).
RT-PCR studies
Three up-regulated anti-viral genes (OAS2, CXCL10,
TRAIL) and a gene (C4bp) that was down-regulated spe-
ciﬁcally in the MRNL were selected for real-time PCR
studies. The expression levels of these genes were deter-
mined in all tissue sample collected from all individual pigs
at 3, 7 and 10 dpi. In addition, IFNa expression and CSFV
replication were also investigated in all these samples
(Figs. 2, 3, 4). In agreement with the microarray data, a
strong up-regulation of anti-viral gene expression was
observed in all three immune tissues collected from LV-,
MV- and HV-infected pigs at 3 dpi. At 7 and 10 dpi, this
highlevelofexpressiondroppedtolowerlevels,andinsome
pigs to the (normal) levels observed in uninfected pigs. In
contrast, PCR results obtained for C4bp expression in
MRLNs of LV- and HV-infected pigs at 3 dpi (Fig. 4) did
not match with the data of the microarray, most likely due to
a naturally occurring high inter-animal variation of C4bp
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123expression in the MRLN (see control animals in Fig. 4).
However, similar to what was observed for the MV strain,
C4bpexpressionwassigniﬁcantlyreducedat7and10 dpiin
MRLNs and spleens of most HV-infected pigs (Figs. 3, 4).
In all three immune organs of most MV- and HV-
infected pigs, a high level of virus seemed to be associated
with a low level of up-regulation of OAS2, CXCL10,
and TRAIL. For LV-infected pigs, this inverse correlation
between viral replication and anti-viral gene expression
was also apparent in spleens and MRLNs obtained at
3 dpi and in spleens obtained at 7 dpi. However, in
spleens and MLRNs collected from LV-infected pigs at
10 dpi, hardly any (or no) viral replication could be
detected and no signiﬁcant up-regulation of these anti-viral
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123genes was observed. These results suggested that
regulation of OAS2, CXCL10, and TRAIL gene expression
in these immune organs is tightly linked to replica-
tion of CSFV. Interestingly, an inverse correlation
between virus replication and IFNa gene expression was
also observed in immune organs of a few infected pigs
(marked with an asterisk in Fig. 4, p-value \0.05).
Because IFNa gene expression in uninfected pigs was
very capricious (see control animals in Fig. 4), more data
are needed to draw conclusions about this.
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In the present study, we investigated the factors involved in
the immune response of pigs during CSFV infection by
determining gene expression proﬁles in immune organs.
We demonstrate the extent of the porcine immune response
against CSFV and the modulation of the host-signalling
pathways by the virus. Besides the up-regulation of a
cluster of IFN-c-induced genes (AIF-1, IFI16, and GBP-2)
in MRLN speciﬁcally induced by low virulent Brescia, no
other pronounced qualitative differences in modulation of
host pathways were detected between the strains of dif-
ferent virulence tested here. This emphasizes the complex
interplay between CSFV and its host, in which subtle dif-
ferences in genetic background of the virus and subtle
differences in host factors, e.g., age and breed [21, 48], are
decisive for the course of this viral disease.
The gene expression proﬁles provided by microarray
indicated that enty and replication of CSFV modulated
every part of the porcine immune system: (1) innate
immunity with its humoral and chemical barriers such as
the complement system and inﬂammation, as well as
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123cellular barriers such as phagocytes, and (2) adaptive
immunity, which involves B cells, killer T cells, and helper
T cells.
Cytokines and chemokines such as IL6, IL8, TNF-a,
IFNs, IL10 and IL12 have been demonstrated to be induced
by CSFV [7, 38]. However, in the present study, CXCL10
is the most strongly up-regulated cytokine. CXCL10 (alias
IP10) has been reported to be involved in effector T cell,
monocyte and NK recruitment in response to infections
with viruses involved in neurological disease, liver disease,
heart disease and hemorrhagic fever disease [1, 18, 41, 44,
45]. It also has a pro-apoptotic effect via the p53-mediated
(intrinsic) apoptotic pathway [76], which, according to our
gene expression proﬁles, was also found to be activated by
CSFV. This suggests that CXCL10 plays an important role
in innate immunity through the recruitment of immune
cells but also as a potential pro-apoptotic factor in CSFV
disease.
The activation of TRAIL by CSFV conﬁrms the con-
clusions of previous studies showing that programmed cell
death is involved in the mechanism of lymphopenia during
CSF [19, 66] and extends the list of death ligands known to
be used by CSFV (TNF-a and FAS). Indeed, TRAIL
functions as an antiviral protein [13, 72] by inducing cell
death in infected cells via the extrinsic pathway but can
also induce immunosuppression. It has been demonstrated
that viruses such as HIV, measles virus, and cytomegalo-
virus infect DCs and induce TRAIL and TNF-a expression
on their surface [64, 71]. Such DCs cannot present antigens
and prime T cells for the generation of virus-speciﬁc CTLs.
Instead, they kill interacting T, B and NK cells via the FAS
and TRAIL/death-receptor pathway. This suggests that
TRAIL plays a key role in the induction of apoptosis in
uninfected cells and is also an immunosuppressor in CSF.
CFSV, by its replication in host cells, induced ER stress
and oxidative stress, which intrinsically trigger apoptosis.
As a countermeasure, several anti-apoptotic genes may
have been activated, such as MCL1 (a gene related to
Bcl-2), glutathione metabolism genes, and the gene for the
Ca
2? regulation/transport protein calbindin. These obser-
vations are in agreement with previous in vitro studies with
bovine virus diarrhoea virus, in which Bcl-2 gene expres-
sion was up-regulated in MDBK cells infected with a
noncytopathic strain and down-regulated in these cells
when infected with a cytopathic strain [6, 40]. This Bcl-2
down-regulation resulted in a reduced production of the
antioxidant glutathione. Other viruses such as African
swine fever virus or Epstein-Barr virus are known to reg-
ulate apoptosis by the synthesis of a viral protein homol-
ogous to Bcl-2 ([54], reviewed in Ref. [22]). Our results
suggest that such anti-apoptotic gene activation, which may
afford signiﬁcant protection against virus-induced cell
death, also may play a role in the pathogenesis of CSFV.
No genes involved in NO metabolism were found to be
regulated by CSFV.
The results show IFN-response-gene activation,
although no signiﬁcant up-regulation of IFN genes was
found. This could be explained either by very early and
short IFN expression (before day 3) [35] or by a low level
of IFN expression produced by plasmacytoid DCs, which
were not inhibited by CSFV [2, 57, 67] and probably
undetectable by microarray due to the relatively low con-
centration of these cells in whole tissue samples.
CSFV also affects the regulation of the complement
system by shutting down the normal host complement
inhibitor C4bp. Since the complement regulator proteins
(C4bp, factor H and factor I) have been shown to be major
targets for inhibition of complement by viruses [20, 25],
this down-regulation could reﬂect a viral defence response.
However, C4pb has been implicated in other functions such
as B-cell activation and the removal of apoptotic cells and
bacteria (reviewed in Ref. [10]). Therefore, further inves-
tigation is necessary for a better comprehension of the
C4bp function in CSF.
Ubiquitin-mediated proteolysis by the proteasome,
another pathway identiﬁed by the microarray, is involved
in directing protein trafﬁcking and degradation (reviewed
in Ref. [46]). In CSFV infection, the proteasome has been
shown to degrade interferon regulatory factor 3 (IRF3)
after interaction with viral protein N-Pro [4, 60], leading to
the interruption of the transcription of IFNs. In addition, it
has been shown that various other viruses can stimulate
ubiquitin-mediated degradation of regulatory factors for
their own beneﬁt, for example, to support evasion of the
host immune system (e.g., MHCI or STAT1 and 2, regu-
lators of IFN expression; [26]), and to suppress apoptosis
(e.g., the degradation of IAP, NFKB or Bcl-2; reviewed in
Ref. [39]). Given that CFSV infection leads to immune
suppression and apoptosis, the ubiquitin-proteasome is
more likely to be used by CSFV to control, in addition of
the IRF3, some of those crucial pathways. Anti-viral gene
expressions (OAS2, CXCL10) and pro-apoptotic gene
expression (TRAIL) showed a marked decrease when the
virus replicated to a high level.
Although the WBC count is low in the animals at that
stage of the disease (7 and 10 dpi), the depletion of T cells
and DC cells does not by itself explain the decrease in gene
expression. All of the gene data were normalized with 18S
and beta-actin genes in order to eliminate this type of error.
In addition, not all of the tested genes showed a decrease in
gene expression. For example, MOP5 (data not shown)
which is also an IFN-induced gene, showed no signiﬁcant
decrease in gene expression at 7 and 10 dpi.
This study also suggests that CSFV can modulate host-
signalling pathways to enhance its persistence and sur-
vival.The exact mechanism of the modulation remains to
1428 S. V. M. Durand et al.
123be elucidated. However, several strategies have already
been identiﬁed to control those pathways. For example,
poliovirus, reovirus and inﬂuenza A virus can inhibit OAS
activation by viral dsRNA-protein binding (reviewed in
Ref. [63]). Several RNA and DNA viruses block IFN
signaling in order to inhibit multiple pathways simulta-
neously, such as cellular antiviral enzymes (OAS, PKR,
Mx1), anti-inﬂammatory response (CXCL10), and death
ligands (TRAIL, FAS, TNF-a; reviewed in Ref. [53]). In
addition to modulation of IFN production by Npro and
Erns [28, 34, 37, 47], the pestivirus BVDV shows modu-
lation of IFN signaling, such as PKR and MX activities, to
establish a persistent infection [29, 59].
In conclusion, the functional analyses of gene expres-
sion show that most of the expressed genes contribute to
anti-virus defense responses and pathogenesis of CSFV,
while others reﬂect viral defense responses. Therefore, our
ﬁndings can provide new insights into understanding the
molecular basis of pathogenesis in CSFV pigs.
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